Business
Celldex to Present at the 2021 Cantor Virtual Global Healthcare Conference
HAMPTON, N.J., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a
About this update from Celldex Therapeutics, Inc.
[{"type":"text","content":"HAMPTON, N.J., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29, 2021 at 1:20 p.m. ET. A webcast of the presentation will be available on the \"Events & Presentations\" page of the \"Investors & Media\" section of the Celldex website. A replay will be available for 30 days following the event. About Celldex Therapeutics, Inc.Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com. Company ContactSarah CavanaughSenior Vice President, Corporate Affairs & Administration(508) [email protected] Patrick TillSenior Director, Investor Relations & Corporate Communications(484) [email protected] \nSource: Celldex Therapeutics, Inc.","length":3696,"tagName":"div"}]